What was Medline's IPO value?

Medline's IPO successfully raised $6.26 billion.

How does Medline's business model compare to Costco?

CEO Jim Boyle likens Medline's membership model for healthcare supplies to Costco's approach.

Are there risks associated with Medline's IPO?

Concerns include Medline's debt and potential stock pressure from private equity holders aiming to liquidate positions.

Home / Business and Economy / Medline IPO Soars: A $6.26B Healthcare Giant Debuts

Medline IPO Soars: A $6.26B Healthcare Giant Debuts

18 Dec, 2025

•

Summary

Medline's IPO raised $6.26 billion, the year's largest globally.
CEO Jim Boyle likens Medline to Costco for healthcare with its membership.
Private equity holders may pressure stock as they aim to liquidate.

Medline IPO Soars: A $6.26B Healthcare Giant Debuts

Medline achieved the largest initial public offering in over four years, successfully raising $6.26 billion. The healthcare supply company's stock opened at $35, a significant increase from its initial pricing of $29, indicating strong market reception.

CEO Jim Boyle highlighted Medline's distinctive business strategy, comparing it to a "Costco for healthcare" with a membership approach and its own branded products. The company's revenue is evenly divided between selling its own surgical items and managing the broader healthcare supply chain, supported by consistent revenue growth and solid profitability.

However, potential investors are advised to consider Medline's balance sheet, which includes notable debt requiring repayment. Furthermore, a substantial portion of Medline is owned by private equity firms, whose eventual liquidation of shares could place downward pressure on the stock price in the long term.